NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine (Q47273564)

13 January 2018

title

NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine (English)

1 reference

13 January 2018

author

William G. Haynes

12

1 reference

13 January 2018

Arne Astrup

8

object named as

Arne Astrup

1 reference

13 January 2018

16

Steven B Heymsfield

1 reference

13 January 2018

1

Ngozi Erondu

1 reference

13 January 2018

author name string

Carol Addy

2

1 reference

13 January 2018

Kaifeng Lu

3

1 reference

13 January 2018

Madhuja Mallick

4

1 reference

13 January 2018

Bret Musser

5

1 reference

13 January 2018

Ira Gantz

6

1 reference

13 January 2018

Joseph Proietto

7

1 reference

13 January 2018

Søren Toubro

9

1 reference

13 January 2018

Aila M Rissannen

10

1 reference

13 January 2018

Serena Tonstad

11

1 reference

13 January 2018

Keith M Gottesdiener

13

1 reference

13 January 2018

Keith D Kaufman

14

1 reference

13 January 2018

John M Amatruda

15

1 reference

13 January 2018

publication date

1 August 2007

1 reference

13 January 2018

published in

Obesity

1 reference

13 January 2018

volume

15

1 reference

13 January 2018

page(s)

2027-2042

1 reference

13 January 2018

issue

8

1 reference

13 January 2018

Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Meta-analysis: pharmacologic treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Assessing Impact of Weight on Quality of Life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Orlistat, a new lipase inhibitor for the management of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Mode of action of tetrahydrolipstatin: a derivative of the naturally occurring lipase inhibitor lipstatin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Sibutramine and the management of obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

The efficacy and safety of sibutramine for weight loss: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

A systematic review of the clinical effectiveness of orlistat used for the management of obesity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

What interventions should we add to weight reducing diets in adults with obesity? A systematic review of randomized controlled trials of adding drug therapy, exercise, behaviour therapy or combinations of these interventions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Central nervous system control of food intake

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

From lesions to leptin: hypothalamic control of food intake and body weight.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

A receptor subtype involved in neuropeptide-Y-induced food intake

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

The first selective agonist for the neuropeptide YY5 receptor increases food intake in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

[D-Trp(34)] neuropeptide Y is a potent and selective neuropeptide Y Y(5) receptor agonist with dramatic effects on food intake

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Food intake inhibition and reduction in body weight gain in lean and obese rodents treated with GW438014A, a potent and selective NPY-Y5 receptor antagonist

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Characterization of Neuropeptide Y (NPY) Y5 Receptor-Mediated Obesity in Mice: Chronic Intracerebroventricular Infusion ofd-Trp34NPY

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Design and synthesis of the potent, orally available, brain-penetrable arylpyrazole class of neuropeptide Y5 receptor antagonists

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Selective antagonism of the NPY Y5 receptor does not have a major effect on feeding in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Role of the Y5 neuropeptide Y receptor in feeding and obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Lipoprotein distribution and composition in obesity: their association with central adiposity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

The MOS 36-ltem Short-Form Health Survey (SF-36)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

EuroQol--a new facility for the measurement of health-related quality of life

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Modern statistical methods for handling missing repeated measurements in obesity trial data: beyond LOCF.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight loss.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

The serotonin (5-HT) antagonist methysergide increases neuropeptide Y (NPY) synthesis and secretion in the hypothalamus of the rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Differential effects of the 5-HT 1B/2C receptor agonist mCPP and the 5-HT1A agonist flesinoxan on hypothalamic neuropeptide Y in the rat: evidence that NPY may mediate serotonin's effects on food intake

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Acute fenfluramine administration reduces neuropeptide Y concentrations in specific hypothalamic regions of the rat: possible implications for the anorectic effect of fenfluramine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Studies on the role of serotonin receptor subtypes in the effect of sibutramine in various feeding paradigms in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Efficacy of sibutramine, orlistat and combination therapy on short-term weight management in obese patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Comparison of efficacy of sibutramine or orlistat versus their combination in obese women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Orlistat, sibutramine, or combination therapy: which performs better on waist circumference in relation with body mass index in obese patients?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.242

https://api.fatcat.wiki/v0/release/fzleqdkjb5cr7pzeylfqvnuq2m

31 March 2020

Identifiers

1 reference

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_fzleqdkjb5cr7pzeylfqvnuq2m

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fzleqdkjb5cr7pzeylfqvnuq2m

mapped directly with Wikidata item

30 July 2022

based on heuristic

1 reference

https://api.fatcat.wiki/v0/release/fzleqdkjb5cr7pzeylfqvnuq2m